泰尼特医疗

最新新闻

• Raymond James Initiates Tenet Healthcare(THC.US) With Buy Rating, Announces Target Price $285
  \u5e02\u573a\u8d44\u8baf · 2026/9/28
• 评级变动
  BofA Securities Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $295
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  A Quick Look at Today's Ratings for Tenet Healthcare(THC.US), With a Forecast Between $263 to $283
  \u5e02\u573a\u8d44\u8baf · 2026/7/27
• 评级变动
  Goldman Sachs Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $305
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• BMO Capital Initiates Tenet Healthcare(THC.US) With Hold Rating, Announces Target Price $265
  \u5e02\u573a\u8d44\u8baf · 2026/9/23
• 公司公告
  The Honest | SC 13G: Statement of acquisition of beneficial ownership by individuals-THC Shared Abacus, LP(13.37%),J. Michael Chu(13.37%), etc.
  SEC · 2022/2/15
• Tenet Healthcare(THC.US) Director Sells US$3.17 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• 评级变动
  UBS Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $308
  \u5e02\u573a\u8d44\u8baf · 2026/8/25
• 评级变动
  A Quick Look at Today's Ratings for Tenet Healthcare(THC.US), With a Forecast Between $263 to $308
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  J.P. Morgan Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $315
  \u5e02\u573a\u8d44\u8baf · 2026/9/2
• 公司公告
  TTJ: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Disclosure of THC Venture Pte. Ltd.'s Interest
  SGX · 2022/8/29
• 评级变动
  Goldman Sachs Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $305
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• Leerink Partners Maintains Tenet Healthcare(THC.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/18
• 评级变动
  Mizuho Securities Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $290
  \u5e02\u573a\u8d44\u8baf · 2026/8/10
• 评级变动
  Morgan Stanley Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $274
  \u5e02\u573a\u8d44\u8baf · 2026/9/14
• 公司公告
  The Honest | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THC Shared Abacus, LP(0%),J. Michael Chu(0%), etc.
  SEC · 2024/11/15
• RBC Capital Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $283
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 公司公告
  TTJ: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-Disclosure of THC Venture Pte. Ltd.'s Interest
  SGX · 2022/7/22
• Form 144 | Tenet Healthcare(THC.US) Director Proposes to Sell 3.21 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/9/15

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。